CD ComputaBio

CD ComputaBio is a private computational biology and drug discovery services company serving pharmaceutical, biotechnology, and academic customers. The company provides in silico and integrated preclinical support spanning molecular docking, molecular dynamics, virtual screening, drug design, bioinformatics, protein engineering, antibody discovery, PROTAC and ADC design, peptide design, and AI-aided R&D services. Its positioning is that of a research services partner rather than a therapeutic product developer, using high-performance computing, artificial intelligence, and modeling workflows to support target identification, lead generation, lead optimization, and biological analysis. CD ComputaBio also markets specialized offerings in genomics, multi-omics, mRNA/LNP design, and computational peptide design. The company appears to operate as an active contract research and computational solutions provider rather than a clinical-stage biotech with a disclosed proprietary pipeline.